LEP and hypersomnia: Cohort and case-control studies [10–13] with more refined assessment tools of somatic symptoms indicated that those pertaining to the “atypical” spectrum—in particular the reversed neurovegetative symptoms of hyperphagia, hypersomnia and weight gain together with leaden paralysis—were more strongly linked to markers of inflammatory and metabolic dysregulations including CRP, IL-6, triglycerides, leptin, insulin and different measures of body fat and adiposity.